177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

European journal of nuclear medicine and molecular imaging

Volumn 41, Issue 10, 2014, Pages 1845-1851

  Paganelli, Giovanni ^a   Sansovini, Maddalena ^a   Ambrosetti, Alice ^a   Severi, Stefano ^a   Monti, Manuela ^a   Scarpi, Emanuela ^a   Donati, Caterina ^a   Ianniello, Annarita ^a   Matteucci, Federica ^a   Amadori, Dino ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(177LUTETIUM-DOTA(O)TYR3)OCTREOTATE; OCTREOTIDE; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMAN; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PHASE 2 CLINICAL TRIAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS;

EID: 84930742473     PISSN: None     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2735-5     Document Type: Article

References (0)